Skip to content

Company · founded 2013

KromaTiD (United States)

Fort Collins, United States · kromatid.com

Manage this page

Citations, last 5 years: 365
Works, last 5 years: 15
h-index: 24
Scientists listed: 2
Grants since 2016: 6

Grants received

2021–2022 · research · R44

A comprehensive quality control testing strategy for engineered cells

Christopher John Tompkins · KromaTiD (United States) · funded by National Institutes of Health

$1.3MCRISPR and Genetic Engineering

2021–2023 · research · R44

A comprehensive quality control testing strategy for engineered cells

Christopher John Tompkins · KromaTiD (United States) · funded by National Institutes of Health

$350.5kCRISPR and Genetic Engineering

2020–2023 · research · R44

Automated, high-throughput identification of genetic structural variants for gene editing and undiagnosed genetic diseases screening

Christopher John Tompkins · KromaTiD (United States) · funded by National Institutes of Health

$584.4k

2020–2022 · research · R44

Automated, high-throughput identification of genetic structural variants for gene editing and undiagnosed genetic diseases screening

Christopher John Tompkins · KromaTiD (United States) · funded by National Institutes of Health

$1.1M

2018–2020 · research · R44

Rapid, cost-effective whole genome screening tools for cryptic inversions and translocations

Christopher John Tompkins · KromaTiD (United States) · funded by National Institutes of Health

$700.6kCRISPR and Genetic Engineering

2018 · research · R44

Rapid, cost-effective whole genome screening tools for cryptic inversions and translocations

Christopher John Tompkins · KromaTiD (United States) · funded by National Institutes of Health

$206.6kCRISPR and Genetic Engineering